Clinical Trial: Glucophage Plus Myo-Inositol Vs. Glucophage in Glycemic Control Among Patients with Gestational Diabetes Mellitus

U.S., Feb. 22 -- ClinicalTrials.gov registry received information related to the study (NCT06840613) titled 'Glucophage Plus Myo-Inositol Vs. Glucophage in Glycemic Control Among Patients with Gestational Diabetes Mellitus' on Feb. 17.

Brief Summary: This randomized controlled trial aims to compare the efficacy of Glucophage plus Myo-Inositol versus Glucophage alone in glycemic control among patients with gestational diabetes mellitus (GDM). The study will assess whether the addition of Myo-Inositol improves glycemic control and reduces insulin requirements in GDM patients. Participants will be randomized into two groups: one receiving Myo-Inositol in combination with Glucophage and the other receiving Glucophage alone. The primary outcome...